FEG
VIVS

Financial Enhancement Group’s VivoSim Labs VIVS Stock Holding History

Financial Enhancement Group’s Portfolio VIVS Stock Details VIVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-10
Closed -$1K – 325
2020
Q3 		$1K Buy
+10
New +$1.29K ﹤0.01% 252

Other funds holding VIVS

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $100M AUM
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Financial Enhancement Group's VIVS Position: Q4 2020 in Review

Financial Enhancement Group sold out of VivoSim Labs (VIVS) in Q4 2020, closing a stake of 10 shares — an estimated $1K sold.

Financial Enhancement Group first reported a position in VIVS in Q3 2020 and held it in 1 quarter. The position peaked at $1K in Q3 2020. 46 funds tracked by Wall St. Rank hold VIVS as of Q4 2020.

  • Financial Enhancement Group reported no remaining VivoSim Labs position as of Q4 2020 after selling out during the quarter.
  • Financial Enhancement Group sold 10 VivoSim Labs shares in Q4 2020, an estimated $1K.
  • Financial Enhancement Group first reported a position in VivoSim Labs in Q3 2020 and held it in 1 quarter.
  • Financial Enhancement Group's VivoSim Labs position peaked at $1K in Q3 2020.
  • 46 funds tracked by Wall St. Rank held VivoSim Labs as of Q4 2020.

Based on Financial Enhancement Group's 13F filing for Q4 2020, filed 10 Feb 2021.